ASX Announcement

Dosing Commences For EMD-RX5 Phase 1 Human Clinical Trial

Published: 07/04/22, 09:45am (AEST)5 pages
Emyria Limited
EMD:ASXHealthcare

Recent EMD Announcements

Price Sensitive only